Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20130311012782N41Phase 3Completed
Phase 3, randomised, double-blind trial in postoperative pain comparing Ropivacaine + dexmedetomidine, Ropivacaine + fentanyl and Ropivacaine control (3 arms). Primary endpoints: Time to reach sensory block, Time to motor block and 5 more. Started Apr 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20130311012782N41.